LOS ANGELES (AP) — LOS ANGELES (AP) — Puma Biotechnology Inc. (PBYI) on Thursday reported earnings of $8.8 million in its third quarter.
On a per-share basis, the Los Angeles-based company said it had net income of 17 cents. Earnings, adjusted for stock option expense, were 21 cents per share.
The biopharmaceutical company posted revenue of $54.5 million in the period.
For the current quarter ending in December, Puma Biotech said it expects revenue in the range of $67 million to $70 million.
The company expects full-year revenue in the range of $220 million to $223 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
